155 related articles for article (PubMed ID: 8613066)
1. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.
Villanueva A; Reyes G; Cuatrecasas M; Martínez A; Erill N; Lerma E; Farré A; Lluís F; Capellá G
Gastroenterology; 1996 May; 110(5):1587-94. PubMed ID: 8613066
[TBL] [Abstract][Full Text] [Related]
2. K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.
Zheng M; Liu LX; Zhu AL; Qi SY; Jiang HC; Xiao ZY
World J Gastroenterol; 2003 Jan; 9(1):188-91. PubMed ID: 12508380
[TBL] [Abstract][Full Text] [Related]
3. K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits.
Mora J; Puig P; Boadas J; Urgell E; Montserrat E; Lerma E; González-Sastre F; Lluís F; Farré A; Capellá G
Clin Chem; 1998 Nov; 44(11):2243-8. PubMed ID: 9799749
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
[TBL] [Abstract][Full Text] [Related]
5. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of pancreatic lesions using fine needle aspiration cytology: detection of K-ras point mutations using solid phase minisequencing.
Ihalainen J; Taavitsainen M; Salmivaara T; Palotie A
J Clin Pathol; 1994 Dec; 47(12):1082-4. PubMed ID: 7876379
[TBL] [Abstract][Full Text] [Related]
7. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.
Evans DB; Frazier ML; Charnsangavej C; Katz RL; Larry L; Abbruzzese JL
Ann Surg Oncol; 1996 May; 3(3):241-6. PubMed ID: 8726178
[TBL] [Abstract][Full Text] [Related]
9. Ki-ras mutations and the carcinoembryonic antigen level in fine needle aspirates of the pancreas.
Pinto MM; Emanuel JR; Chaturvedi V; Costa J
Acta Cytol; 1997; 41(2):427-34. PubMed ID: 9100777
[TBL] [Abstract][Full Text] [Related]
10. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.
Bartsch D; Bastian D; Barth P; Schudy A; Nies C; Kisker O; Wagner HJ; Rothmund M
Ann Surg; 1998 Jul; 228(1):79-86. PubMed ID: 9671070
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
12. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
[TBL] [Abstract][Full Text] [Related]
13. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor.
Tada M; Komatsu Y; Kawabe T; Sasahira N; Isayama H; Toda N; Shiratori Y; Omata M
Am J Gastroenterol; 2002 Sep; 97(9):2263-70. PubMed ID: 12358243
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
[TBL] [Abstract][Full Text] [Related]
17. Mutational activation of the c-K-ras gene in human pancreatic carcinoma.
Shibata D; Capella G; Perucho M
Baillieres Clin Gastroenterol; 1990 Mar; 4(1):151-69. PubMed ID: 1976394
[TBL] [Abstract][Full Text] [Related]
18. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.
Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N
Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
[TBL] [Abstract][Full Text] [Related]
20. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
